Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Ellis SG. AE Abdelmeguid, SG Ellis, SK Sapp, PL Whitlow… - American Heart …, 1996 - Elsevier GSID: lZZGPiRNpNcJ
Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. Klein LW. LW Klein, BL Kramer, E Howard, M Lesch - Journal of the American College …, 1991 - Elsevier GSID: PsEttWqR6TMJ
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Topol EJ. EJ Topol, EPISTENT Investigators - The Lancet, 1998 - Elsevier GSID: TBucWtVsXeAJ
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. [No authors listed] Epilog Investigators - New England Journal of Medicine, 1997 - Mass Medical Soc GSID: lSXU8icBbNAJ
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association …. Smith SC. SC Smith Jr, TE Feldman, JW Hirshfeld Jr… - Journal of the American …, 2006 - Elsevier GSID: 4vqA2hWRv6wJ